Innovex International, Inc.
Innovex International, Inc. Fundamental Analysis
Innovex International, Inc. (INVX) shows moderate financial fundamentals with a PE ratio of 17.29, profit margin of 10.58%, and ROE of 10.19%. The company generates $1.0B in annual revenue with strong year-over-year growth of 18.95%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze INVX's fundamental strength across five key dimensions:
Efficiency Score
WeakINVX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentINVX trades at attractive valuation levels.
Growth Score
ExcellentINVX delivers strong and consistent growth momentum.
Financial Health Score
ExcellentINVX maintains a strong and stable balance sheet.
Profitability Score
WeakINVX struggles to sustain strong margins.
Key Financial Metrics
Is INVX Expensive or Cheap?
P/E Ratio
INVX trades at 17.29 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, INVX's PEG of -0.35 indicates potential undervaluation.
Price to Book
The market values Innovex International, Inc. at 1.68 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.06 times EBITDA. This is generally considered low.
How Well Does INVX Make Money?
Net Profit Margin
For every $100 in sales, Innovex International, Inc. keeps $10.58 as profit after all expenses.
Operating Margin
Core operations generate 10.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.19 in profit for every $100 of shareholder equity.
ROA
Innovex International, Inc. generates $8.06 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Innovex International, Inc. produces operating cash flow of $175.31M, showing steady but balanced cash generation.
Free Cash Flow
Innovex International, Inc. generates strong free cash flow of $141.42M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $2.05 in free cash annually.
FCF Yield
INVX converts 8.05% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
17.29
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.35
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.68
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.83
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.08
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.78
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How INVX Stacks Against Its Sector Peers
| Metric | INVX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 17.29 | 20.19 | Better (Cheaper) |
| ROE | 10.19% | 1019.00% | Weak |
| Net Margin | 10.58% | -44017.00% (disorted) | Strong |
| Debt/Equity | 0.08 | -0.65 (disorted) | Distorted |
| Current Ratio | 4.78 | 4.60 | Strong Liquidity |
| ROA | 8.06% | -11655350.00% (disorted) | Weak |
INVX outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Innovex International, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
14.81%
Industry Style: Cyclical, Value, Commodity
High GrowthEPS CAGR
5779.89%
Industry Style: Cyclical, Value, Commodity
High GrowthFCF CAGR
358.80%
Industry Style: Cyclical, Value, Commodity
High Growth